0001012975-14-000027.txt : 20140117
0001012975-14-000027.hdr.sgml : 20140117
20140117171224
ACCESSION NUMBER: 0001012975-14-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140110
FILED AS OF DATE: 20140117
DATE AS OF CHANGE: 20140117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TRV GP, LLC
CENTRAL INDEX KEY: 0001578973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 14535834
BUSINESS ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Third Rock Ventures GP, L.P.
CENTRAL INDEX KEY: 0001578976
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 14535835
BUSINESS ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THIRD ROCK VENTURES LP
CENTRAL INDEX KEY: 0001408591
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 14535836
BUSINESS ADDRESS:
STREET 1: 29 NEWBURY STREET
STREET 2: SUITE 401
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-859-3099
MAIL ADDRESS:
STREET 1: 29 NEWBURY STREET
STREET 2: SUITE 401
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-01-10
0001293971
bluebird bio, Inc.
BLUE
0001408591
THIRD ROCK VENTURES LP
29 NEWBURY STREET, 3RD FLOOR
BOSTON
MA
02116
0
0
1
0
0001578976
Third Rock Ventures GP, L.P.
29 NEWBURY STREET, 3RD FLOOR
BOSTON
MA
02116
0
0
1
0
0001578973
TRV GP, LLC
29 NEWBURY STREET, 3RD FLOOR
BOSTON
MA
02116
0
0
1
0
Common Stock
2014-01-15
4
S
0
260000
22.14
D
2713974
D
Common Stock
2014-01-16
4
S
0
33000
24.02
D
2680974
D
Common Stock
2014-01-17
4
S
0
14000
23.96
D
2666974
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.650, inclusive. Each Reporting Person undertakes to provide to bluebird bio Inc., any security holder of bluebird bio Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC") and, as such, each of TRV GP and TRV GP LLC exercises shared voting and investment power over the shares held of record by TRV. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.125, inclusive. Each Reporting Person undertakes to provide to bluebird bio Inc., any security holder of bluebird bio Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.80 to $24.36, inclusive. Each Reporting Person undertakes to provide to bluebird bio Inc., any security holder of bluebird bio Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Kevin Gillis, Chief Financial Officer of TRV GP, LLC, general partner of Third Rock Ventures GP, L.P., general partner of Third Rock Ventures, L.P.
2014-01-17
/s/ Kevin Gillis, Chief Financial Officer of TRV GP, LLC, general partner of Third Rock Ventures GP, L.P.
2014-01-17
/s/ Kevin Gillis, Chief Financial Officer of TRV GP, LLC
2014-01-17